Peng Jun | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.

 

Takeshi Sakurai | Neuroanatomy | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Takeshi Sakurai | Neuroanatomy | Best Researcher Award

Prof. Dr. Takeshi Sakurai, University of Tsukuba, Japan.

Takeshi Sakurai, M.D., Ph.D., is a distinguished academic whose career spans across key positions in neuroscience, pharmacology, and integrative sleep medicine. After earning his M.D. and Ph.D. from the University of Tsukuba, he embarked on a journey of groundbreaking research, primarily focusing on neurotransmission and sleep regulation. Sakurai’s postdoctoral work in prestigious institutions, coupled with his leadership of major projects like the Yanagisawa Orphan Receptor Project, established him as a leader in molecular neuroscience. Over the years, he has earned recognition through accolades and significant academic positions, including his current role as Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research continues to shape the understanding of sleep and brain function, while his influence extends to mentoring the next generation of scientists.

Profile

Google Scholar

Early Academic Pursuits 📚


Takeshi Sakurai’s academic journey began with his medical studies at the University of Tsukuba, where he earned his M.D. in 1989. During his early years at the university, he developed a keen interest in the molecular mechanisms of biological systems. This curiosity led him to pursue a Ph.D. in medicine, which he completed in 1993. His doctoral research focused on the cloning of a cDNA encoding a non-isopetide-selective subtype of the endothelin receptor, a project that was published in Nature in 1990, marking the beginning of his significant contributions to molecular pharmacology.

Professional Endeavors 👨‍⚕️


Following his Ph.D., Sakurai embarked on a promising career in academic research, starting as a postdoctoral fellow at the Institute of Basic Medical Sciences in 1993. His career rapidly advanced as he took on various roles, including Assistant Professor at the same institute. During his tenure, he also worked as a postdoctoral fellow at the prestigious Howard Hughes Medical Institute at the University of Texas Southwestern Medical Center in Dallas from 1995 to 1996. These experiences broadened his expertise in pharmacology and molecular neuroscience, laying the foundation for his future academic leadership roles. By 1999, he became an Associate Professor at the University of Tsukuba and contributed significantly to the university’s research landscape.

Contributions and Research Focus 🧬


Sakurai’s research is primarily centered around molecular neuroscience, pharmacology, and integrative physiology. His work has been pivotal in advancing the understanding of biological systems and their regulation at the molecular level. Notably, his leadership of the Yanagisawa Orphan Receptor Project under the Exploratory Research for Advanced Technology (ERATO) of the Japan Science and Technology Corporation highlights his role in pioneering research on orphan receptors. His continued focus on the mechanisms of neurotransmission and their involvement in sleep regulation has earned him a place as a leading researcher in the field of integrative sleep medicine.

Accolades and Recognition 🏆


Throughout his career, Sakurai has earned widespread recognition for his contributions to medicine and neuroscience. His groundbreaking work on neurotransmitter systems and sleep regulation has led to his appointment as a Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research has not only shaped the scientific community’s understanding of brain function but also garnered him numerous accolades, further cementing his reputation as a thought leader in the field.

Impact and Influence 🌍


Sakurai’s impact extends far beyond his own research. As a professor, he has mentored countless students and researchers who have gone on to make their own significant contributions in the fields of neuroscience and pharmacology. His interdisciplinary approach to sleep medicine has influenced research on neurodegenerative diseases, mental health, and drug development. The work he has pioneered in molecular neuroscience has also paved the way for advances in treatment approaches for disorders related to sleep and neurotransmission, offering hope for improved therapeutic interventions.

Legacy and Future Contributions 🔬


Looking ahead, Sakurai’s legacy in neuroscience and integrative sleep medicine is poised to continue influencing both academic research and clinical practice. His innovative research on sleep regulation and the molecular mechanisms underpinning brain function will undoubtedly remain foundational in the future of both basic and applied medical sciences. As he continues his work at the University of Tsukuba, Sakurai’s future contributions will likely expand our understanding of the brain’s intricate systems and their broader implications for human health. His career exemplifies a dedication to advancing science, and his ongoing research promises to address critical challenges in medicine and health.

Academic Leadership and Mentorship 🎓


In addition to his personal research achievements, Sakurai’s role in academic leadership cannot be understated. As a professor at the University of Tsukuba, he has played a pivotal role in shaping the institution’s research direction and academic programs, particularly within the fields of integrative physiology and sleep medicine. His influence extends through the mentorship of students, guiding the next generation of researchers who will continue to build on his work. Sakurai’s commitment to education and his support for innovative research initiatives are key to his lasting impact on the academic and medical communities.

Publication

  • Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
    Authors: T Sakurai, A Amemiya, M Ishii, I Matsuzaki, RM Chemelli, H Tanaka, …
    Year: 1998

 

  • Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
    Authors: T Sakurai, M Yanagisawa, Y Takuwat, H Miyazakit, S Kimura, K Goto, …
    Year: 1990

 

  • Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
    Authors: J Hara, CT Beuckmann, T Nambu, JT Willie, RM Chemelli, CM Sinton, …
    Year: 2001

 

  • Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
    Authors: JT Glessner, K Wang, G Cai, O Korvatska, CE Kim, S Wood, H Zhang, …
    Year: 2009

 

  • The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
    Author: T Sakurai
    Year: 2007

 

  • Distribution of orexin neurons in the adult rat brain
    Authors: T Nambu, T Sakurai, K Mizukami, Y Hosoya, M Yanagisawa, K Goto
    Year: 1999

 

  • Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
    Authors: Y Date, Y Ueta, H Yamashita, H Yamaguchi, S Matsukura, K Kangawa, …
    Year: 1999

 

  • Hypothalamic orexin neurons regulate arousal according to energy balance in mice
    Authors: A Yamanaka, CT Beuckmann, JT Willie, J Hara, N Tsujino, M Mieda, …
    Year: 2003

 

  • Plastic stress-strain matrix and its application for the solution of elastic-plastic problems by the finite element method
    Authors: Y Yamada, N Yoshimura, T Sakurai
    Year: 1968

 

  • Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
    Authors: CF Elias, CB Saper, E Maratos‐Flier, NA Tritos, C Lee, J Kelly, JB Tatro, …
    Year: 1998

 

Conclusion


Takeshi Sakurai’s work has profoundly impacted the fields of neuroscience, pharmacology, and sleep medicine. His contributions have not only advanced scientific understanding but have also paved the way for practical applications in medical therapies. Through his leadership and mentorship, Sakurai’s legacy is set to endure, with his future research promising further advancements in understanding the complexities of the brain and its regulation. His dedication to advancing both science and education ensures that his influence will continue to resonate in academic and clinical circles for years to come.

 

Rita Abi Rached | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Rita Abi Rached | Neuropharmacology | Best Researcher Award

Dr. Rita Abi Rached, University of Cagliari, Italy.

Rita Joseph Abi Rached has built a remarkable career at the intersection of food chemistry, biochemistry, and sustainability. From her foundational academic journey to her current research in agri-food by-product valorization, she has continuously sought innovative solutions to environmental and health-related challenges. Her expertise spans industry collaborations, cutting-edge research, and impactful scientific contributions, making her a leading figure in sustainable food science.

Profile

Google Scholar

✨ Early Academic Pursuits – A Passion for Science ✨

From an early age, Rita Joseph Abi Rached demonstrated an innate curiosity for the sciences, particularly in the fields of biochemistry and food chemistry. She embarked on her academic journey with a Bachelor’s degree in Biochemistry from Saint Joseph University of Beirut in 2017, where she cultivated a strong foundation in molecular sciences. Her passion for the chemical intricacies of food systems led her to pursue a Master’s degree in Food Chemistry in 2019, further refining her expertise in the biochemical properties of agro-food products. This academic dedication ultimately culminated in a Double Ph.D. in Life, Environmental, and Pharmaceutical Sciences from the University of Cagliari and Saint Joseph University of Beirut in 2024, marking a significant milestone in her scholarly endeavors.

🌱 Professional Endeavors – Bridging Academia and Industry 🌱

With an unwavering commitment to research, Rita transitioned from academia to professional scientific exploration. Her early training included hands-on experiences at Château Ksara, where she assessed grape phenolic maturity, and at Libby’s, where she gained insights into quality control and microbiological analyses. Further strengthening her industrial expertise, she worked as a lab researcher and research assistant at Saint Joseph University, refining her skills in polyphenol analysis and microbiological assessments. These experiences not only expanded her technical competencies but also paved the way for her role as a dedicated researcher at the University of Cagliari, where she currently investigates sustainable approaches to agri-food by-product valorization.

🤝 Contributions and Research Focus – Innovating for a Sustainable Future 🤝

Rita’s research is deeply rooted in sustainability and the innovative utilization of agricultural and industrial biomasses. Her current work revolves around the valorization of agro-industrial by-products, transforming waste into functional bioactive compounds for health and agriculture. She has actively contributed to groundbreaking projects such as BESTMEDGRAPE, which applied nanotechnological strategies to enhance Mediterranean grape derivatives, and MEDLENTISK, an Erasmus+ initiative that explored best practices for mastic tree fixed oil. Additionally, she played a pivotal role in TECNOCOVID, a project leveraging natural bioactives and nanotechnologies to combat COVID-19. Her most recent endeavor, NUTRINNOVA, focuses on utilizing nutriosomes derived from agro-industrial waste to mitigate dysbiosis, oxidative stress, and cognitive decline, further establishing her as a pioneer in sustainable food research.

🏆 Accolades and Recognition – A Scholar’s Journey 🏆

Throughout her career, Rita has garnered significant recognition for her impactful contributions to scientific research. Her work has been widely cited, with a citation index of 72 and an h-index of 4, reflecting her influence in the academic community. These achievements underscore the relevance of her studies in the fields of food science, biotechnology, and environmental sustainability. Her research outputs continue to inspire new approaches to the responsible and efficient use of natural resources, positioning her as a respected voice in her domain.

🔍 Impact and Influence – Shaping the Scientific Landscape 🔍

As an advocate for innovative and sustainable research, Rita’s work has transcended the boundaries of traditional food science, merging interdisciplinary methodologies to address global challenges. By focusing on agri-food waste valorization, she has provided meaningful insights into reducing environmental impact while enhancing the nutritional and therapeutic value of food by-products. Her collaborations with industry leaders and academic institutions have reinforced her reputation as a key contributor to cutting-edge scientific advancements.

 

Publication

  • Title: Entrapment of Citrus limon var. pompia Essential Oil or Pure Citral in Liposomes Tailored as Mouthwash for the Treatment of Oral Cavity Diseases
    Author(s): L Palmas, M Aroffu, GL Petretto, E Escribano-Ferrer, O Díez-Sales, …
    Year: 2020

 

  • Title: Extraction, Characterization and Incorporation of Hypericum scruglii Extract in Ad Hoc Formulated Phospholipid Vesicles Designed for the Treatment of Skin
    Author(s): M Allaw, M Manconi, M Aroffu, F Marongiu, M Porceddu, G Bacchetta, …
    Year: 2020

 

  • Title: Optimization of Polyphenols Extraction from Purple Corn Cobs Using ß-Cyclodextrin as a Green Solvent
    Author(s): HN Rajha, S Khabbaz, R Abi Rached, E Debs, RG Maroun, N Louka
    Year: 2020

 

  • Title: From Grape By-Products to Enriched Yogurt Containing Pomace Extract Loaded in Nanotechnological Nutriosomes Tailored for Promoting Gastro-Intestinal Wellness
    Author(s): I Castangia, F Fulgheri, FJ Leyva-Jimenez, ME Alañón, ML Cádiz-Gurrea, …
    Year: 2023

 

  • Title: From Field to Waste Valorization: A Preliminary Study Exploring the Impact of the Wine Supply Chain on the Phenolic Profile of Three Sardinian Pomace Extracts
    Author(s): I Castangia, M Aroffu, F Fulgheri, R Abi Rached, F Corrias, G Sarais, …
    Year: 2024

 

  • Title: Innovation in Cannon Puffing Technology for the Homogenization of Bulk Treatment: Half‐Popped Purple Corn, a New Healthy Snack
    Author(s): HN Rajha, E Debs, R Abi Rached, K El Khoury, M Al‐Kazzi, R Mrad, …
    Year: 2021

 

  • Title: Exploring the Efficacy and Industrial Potential of Polyphenol Products from Grapes and Their By-Products
    Author(s): R Abi Rached, M Perra, ML Manca, HN Rajha, N Louka, RG Maroun, …
    Year: 2024

 

  • Title: A Preliminary Investigation on Hydrogel Disks Imbibed with Enriched Transfersomes as a Promising Tool to Promote the Cutaneous Deposition of Vaccine Antigens
    Author(s): M Aroffu, R Abi Rached, I Castangia, P Italiani, L D’Apice, …
    Year: 2024

 

  • Title: Preliminary Evaluation of the In Vitro and In Vivo Efficacy of a Novel Nanovesicle-Doped Nanoemulsion Co-Loading Artemisinin and Quercetin as a Promising Strategy to Improve …
    Author(s): F Fulgheri, M Ramírez, L Román-Álamo, P Gasco, M Manconi, M Aroffu, …
    Year: 2025

 

  • Title: Clinical Trial to Evaluate the Effect of Grape Seed Extract-Loaded Hyalurosomes on Skin Wellness
    Author(s): RA Rached, M Habre, Y Salem, J Khodeir, M Allaw, I Castangia, …
    Year: 2025

 

🔗 Conclusion 🔗

With an unwavering passion for science and an unrelenting drive for discovery, Rita Joseph Abi Rached stands as a beacon of innovation, inspiring future generations to embrace sustainability, research, and the transformative power of science. Her legacy in food science and biochemistry will continue to shape the future of sustainable research, leaving a lasting impact on both academia and industry.

Gulcan Tascatan | Neuroscience of Pain | Best Researcher Award

Published on by Neuroscientists

Dr. Gulcan Tascatan | Neuroscience of Pain | Best Researcher Award

Dr. Gulcan Tascatan,  Zonguldak Alapli State Hospital,  Turkey.

Dr. Gülcan Taşçatan is a distinguished neurologist whose journey began with her medical education at Hacettepe University Kastamonu Faculty of Medicine. She specialized in neurology at Zonguldak Bülent Ecevit University and has since built an impressive career, holding key positions in various healthcare institutions. Her research focuses on migraines, chronic headaches, multiple sclerosis, and stroke-related neurological conditions, contributing valuable insights to the field. Her publications in esteemed medical journals and active participation in international conferences highlight her dedication to advancing neurology. As the Chief Physician at Zonguldak Alaplı State Hospital, she not only leads medical teams but also shapes healthcare practices and inspires future medical professionals.

Profile

Orcid

 

📚 Early Academic Pursuits

Gülcan Taşçatan embarked on her academic journey with a passion for medicine, graduating from Hacettepe University Kastamonu Faculty of Medicine in 2015. Her dedication to neurology led her to pursue specialization at Zonguldak Bülent Ecevit University Faculty of Medicine, where she earned her expertise in neurology in 2021. Her early academic years laid a strong foundation for her future contributions to the medical field, shaping her understanding of complex neurological disorders and treatment approaches.

💼 Professional Endeavors

Dr. Gülcan Taşçatan has had an illustrious career, serving in multiple prestigious healthcare institutions. She started as a general practitioner at Kars Digor Community Health Center before advancing her expertise as a research assistant at Zonguldak Bülent Ecevit University Neurology Department. Her journey continued as a neurology specialist at Zonguldak Kdz. Ereğli State Hospital, where she refined her skills in treating neurological conditions. Currently, she holds the esteemed position of Chief Physician at Zonguldak Alaplı State Hospital, demonstrating her leadership and commitment to enhancing healthcare services.

🧠 Contributions and Research Focus

Dr. Taşçatan has significantly contributed to the field of neurology, focusing on chronic headaches, migraines, multiple sclerosis, and stroke-related neurological conditions. Her research delves into understanding risk factors for chronic daily headaches and medication-overuse headaches, as evidenced by her publication in Brain and Behavior. She has also explored the effectiveness of greater occipital nerve blocks in chronic migraines and examined the correlation between silent cerebral lesions and lipid profiles in stroke patients. Through her research, she has advanced medical knowledge in neurology and offered new insights into diagnosis and treatment strategies.

🏅 Accolades and Recognition

Her dedication to research and clinical excellence has earned her recognition in the medical community. Dr. Taşçatan’s work has been published in well-respected international journals indexed in SCIE, EBSCO, and TR Dizin. She has also contributed as a peer reviewer, ensuring high academic standards in neurology publications. Furthermore, her research on multiple sclerosis, published in the Journal of Multiple Sclerosis Research, has been referenced in various scholarly articles, highlighting her impact on the field.

📖 Scientific Contributions and Publications

Beyond her research papers, Dr. Taşçatan has contributed to scientific literature by co-authoring a chapter on Parkinson’s disease treatment in the medical book Sağlık & Bilim 2024 Güncel Tıp-IV. Her participation in national and international neurology conferences, such as the 54th National Neurology Congress and the Global Migraine and Pain Society Meeting, further showcases her dedication to academic knowledge-sharing and medical advancements.

🌍 Impact and Influence

Dr. Taşçatan’s influence extends beyond academia into clinical practice and medical leadership. As a chief physician, she plays a pivotal role in shaping healthcare policies, improving patient care, and mentoring young medical professionals. Her commitment to neurology not only benefits her patients but also inspires future neurologists to pursue excellence in the field. Her research findings have contributed to a better understanding of neurological diseases, guiding new treatment methodologies and improving patient outcomes.

🔬 Legacy and Future Contributions

With a promising career ahead, Dr. Taşçatan continues to push the boundaries of neurology research and clinical innovation. Her commitment to studying complex neurological disorders and refining treatment methods ensures that she will leave a lasting impact on the medical community. By fostering new research, mentoring aspiring doctors, and leading healthcare initiatives, she paves the way for future advancements in neurology, solidifying her legacy as a dedicated physician, researcher, and medical leader.

Publication

  • Title: Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication‐Overuse Headache
    Author(s): Gülcan Taşçatan, Hüseyin Tuğrul Atasoy, Esra Acıman Demirel, Vildan Çakır Kardeş, Mustafa Açıkgöz, Ulufer Çelebi, Bilge Piri Çınar, Bilgehan Açıkgöz, Aynur Özge
    Year: 2025

 

  • Title: Effectiveness of Greater Occipital Nerve Blocks in Chronic Migraine
    Author(s): Esra Acıman Demirel, Burcu Karpuz, Sibel Özdemir, Gülcan Kalaycı, Hüseyin Tuğrul Atasoy
    Year: 2021

 

  • Title: Relationship Between Physical Disability and Black Holes in Multiple Sclerosis: Upper Extremity Functions – an Important Parameter
    Author(s): Bilge Piri Cinar, Gülcan Kalaycı, Mustafa Acikgoz, Serkan Ozakbas
    Year: 2021

 

  • Title: Evaluation of the Relationship Between Silent Cerebral Lesions and Triglyceride/HDL-Cholesterol in Patients With First Stroke Attack
    Author(s): Esra Acıman Demirel, Gülcan Kalaycı, Mustafa Açikgöz, Ulufer Çelebi, Bilge Cinar, Hüseyin Tuğrul Atasoy
    Year: 2020

Conclusion

Dr. Taşçatan’s journey exemplifies a profound commitment to neurology, research, and patient care. Her scientific contributions, leadership in healthcare, and influence in medical academia make her a key figure in the field. With a strong foundation in research and clinical expertise, she continues to push the boundaries of neurology, leaving a lasting impact on medical science. As she progresses in her career, her work will undoubtedly shape future advancements in neurological research and treatment, ensuring better healthcare outcomes for patients worldwide.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Jun Xia | Central Nerous System | Best Scholar Award

Published on by Neuroscientists

Dr. Jun Xia | Central Nerous System| Best Scholar Award

Dr. Jun Xia,  Shenzhen Second People’s Hospital, China.

Dr. Jun Xia, Chief Physician and Deputy Director of the Department of Medical Imaging at Shenzhen Second People’s Hospital, is a distinguished expert with over 30 years of experience in medical imaging. His work focuses on neurological diagnostics, functional imaging, AI-assisted diagnostics, and rare disease consultations. Dr. Xia has published 52 journal articles, including 39 SCI papers with a cumulative impact factor exceeding 100, and authored six books. He holds three patents and has led 15 research projects, including collaborations on pioneering AI-based diagnostic tools. His expertise is recognized globally through editorial appointments, conference presentations, and professional memberships.

 

profile

Scholar

🎓 Academic and Professional Background

Dr. Jun Xia, a Ph.D. holder and medical imaging expert, boasts 30+ years of experience in neurological diagnostics, functional imaging, AI-assisted diagnostics, and rare disease consultations.  He has published 39 SCI papers with an impact factor exceeding 100, reviewed national research funds, and presented at top-tier conferences such as RSNA and ECR.

💡 Research and Innovations

Completed/Ongoing Research Projects: 15. Citation Index: Not specified. Consultancy/Industry Projects: Not specified.Books Published (ISBN): 6.ISBN: 9787117274296, 9787117235983, 9787535767066, 9787535767080, 9787523513552, 9787117331340.Patents Published/Under Process: 3.Journals Published (SCI, Scopus, etc.): 52

Representative Papers:

European Radiology (2024): Feasibility of CT-based synthetic brain T1-weighted MRI.Information Fusion (2022): Explainable AI via multi-modal and multi-centre data fusion.European Radiology (2022): MRI neuroimaging for prognosis in hydrocephalus patients post-shunt surgery.Neural Computing & Applications (2022): AI-based e-Diagnosis for ventricular volume measurement.Quantitative Imaging in Medicine and Surgery (2022): MRI synthesis from CT using CNNs with contextual loss.

🌐 Professional Memberships

Member, Head and Neck Committee, Radiology Branch, Chinese Medical Association.Member, Neuroregeneration and Repair Professional Committee, Chinese Research Hospital AssociationMember, Magnetic Resonance Application Professional Committee, China Medical EquipmentAssociation.Member, Neurology Group, Radiology Branch, Guangdong Medical AssociationMember, Radiology Branch, Shenzhen Medical Association

🏆 Contributions

Dr. Jun Xia has made exceptional contributions in medical imaging, excelling in advanced diagnostic techniques for CNS, musculoskeletal, and abdominal diseases. His expertise in neuroimaging and AI-assisted diagnostics has led to groundbreaking solutions in patient care. With numerous impactful publications and clinical innovations, he continues to advance the field of medical imaging.

📚 Publications

  • Artificial intelligence distinguishes COVID-19 from community-acquired pneumonia on chest CT
    Authors: L Li, L Qin, Z Xu, Y Yin, X Wang, B Kong, J Bai, Y Lu, Z Fang, Q Song, …
    Year: 2020

 

  • Using artificial intelligence to detect COVID-19 and community-acquired pneumonia based on pulmonary CT: evaluation of the diagnostic accuracy
    Authors: L Li, L Qin, Z Xu, Y Yin, X Wang, B Kong, J Bai, Y Lu, Z Fang, Q Song, …
    Year: 2020

 

  • Unbox the black-box for the medical explainable AI via multi-modal and multi-centre data fusion: A mini-review, two showcases and beyond
    Authors: G Yang, Q Ye, J Xia
    Year: 2022

 

  • Weakly supervised deep learning for COVID-19 infection detection and classification from CT images
    Authors: S Hu, Y Gao, Z Niu, Y Jiang, L Li, X Xiao, M Wang, EF Fang, …
    Year: 2020

 

  • Precise diagnosis of intracranial hemorrhage and subtypes using a three-dimensional joint convolutional and recurrent neural network
    Authors: H Ye, F Gao, Y Yin, D Guo, P Zhao, Y Lu, X Wang, J Bai, K Cao, Q Song, …
    Year: 2019

 

  • A single-center, retrospective study of COVID-19 features in children: a descriptive investigation
    Authors: H Ma, J Hu, J Tian, X Zhou, H Li, MT Laws, LD Wesemann, B Zhu, …
    Year: 2020

 

  • Swin transformer for fast MRI
    Authors: J Huang, Y Fang, Y Wu, H Wu, Z Gao, Y Li, J Del Ser, J Xia, G Yang
    Year: 2022

 

  • Explainable AI for COVID-19 CT classifiers: an initial comparison study
    Authors: Q Ye, J Xia, G Yang
    Year: 2021

 

  • Radiomics nomogram building from multiparametric MRI to predict grade in patients with glioma: a cohort study
    Authors: Q Wang, Q Li, R Mi, H Ye, H Zhang, B Chen, Y Li, G Huang, J Xia
    Year: 2019

 

  • Learning tree-structured representation for 3D coronary artery segmentation
    Authors: B Kong, X Wang, J Bai, Y Lu, F Gao, K Cao, J Xia, Q Song, Y Yin
    Year: 2020

 

Conclusion

Dr. Jun Xia’s contributions to medical imaging have significantly advanced the field, particularly in AI-driven diagnostics and functional neuroimaging. His innovative research, extensive publications, and clinical applications underscore his status as a leader in the domain. With a proven track record of excellence and groundbreaking work, Dr. Xia exemplifies the qualities of a visionary researcher and a transformative figure in medical imaging.

 

 

Hanaa Ali | Neurotoxicity | Best Researcher Award

Published on by Neuroscientists

Prof. Hanaa Ali | Neurotoxicity | Best Researcher Award

Prof. Hanaa Ali, National Research Centre, Egypt.

Dr. Hanaa Mahmoud Sayed Ali is a distinguished Egyptian researcher specializing in Biology, Zoology, and Molecular Genetics. With a Ph.D. in Zoology (Genetics and Cytology) from Ain Shams University, she has a career spanning over 25 years, contributing significantly to academic research and teaching.Her research contributions include membership in several scientific research groups and administrative roles that enhance student development and academic governance. Dr. Hanaa is an active member of several scientific societies, contributing to advancements in radiological, nuclear, and medical research.

 

profile

Scopus

🎓 Educational Background

Ph.D. in Zoology (Genetics and Cytology),Faculty of Science, Ain Shams University, 2008.M.Sc. in ZoologyFaculty of Science, Ain Shams University, 2003.B.Sc. in Zoology,Faculty of Science, Ain Shams University, June 1997 (Grade: Very Good ).

🏢 Professional Career

Professor Researcher (National Research Centre, Cairo, Egypt), From 16/11/2023 – Present.Assistant Researcher Professor (National Research Centre, Cairo, Egypt). 30/09/2018 – 15/11/2023.Assistant Professor (Common First Year Deanship, King Saud University, Saudi Arabia),28/09/2010 – 31/08/2020 (Health Track Supervisor).Researcher (National Research Centre, Cairo, Egypt),31/07/2008 – 29/09/2018.Researcher Assistant (National Research Centre, Cairo, Egypt),08/05/2004 – 30/07/2008.Fellowship (Demonstrator) (Faculty of Science, Ain Shams University).1998 – 2003.Part-Time Demonstrator (Faculty of Dentistry, 6th of October University),1999 – 2001.

📚 Teaching Experience

Zoology and Histology Courses for various disciplines:Dentistry, Pharmacy, and Science faculties.Topics include Cytology, Histology, Physiology, Parasitology, Invertebrates, Vertebrates, and Genetics.

🔬 Research Projects

Pharmacology Project (Research Group No. RG-1438-061),Deanship of Scientific Research, King Saud University.Pharmacology and Toxicology Projects,Research Group Nos. RG-1439-017 and RG-1439-638Deanship of Scientific Research, King Saud University

🛠️ Administrative Experience

Supervision of Health Track (Common First Year Deanship, King Saud University).Committee Memberships Review student problems .Establishment of Advisory Council .Course accommodations  (Buildings 25 & 26).Scheduling Committee.

🌐 Memberships in Scientific Societies

Member of the Scientific Professions Syndicate.Member of the Egyptian Society for Radiological Sciences and Its Applications.Member of the Egyptian Society for Nuclear Sciences and Its Applications.Member of the Scientific Society for Medical Research.

📚 Publications

  • Genetic Profile of Gamma Irradiated Locusta migratoria migratorioides: A Futuristic Eco-friendly Control Approach
    • Authors: Ali, H.M.; Fathy, Z.; Ibrahim, S.S.; Sayed, R.M.
    • Year: 2024

 

  • Estimating the Impact of Gamma Radiation on Biochemical Aspects and DNA Damage by Comet Assay in Galleria mellonella Male
    • Authors: Afify, A.; Ali, H.M.; Sayed, R.M.
    • Year: 2024

 

  • Fischer’s Oligopeptide Ratio in Ischemic Hypoxia: Prophylactic Amendment of Sophoretin and Melatonin Supplementation
    • Authors: Kadry, M.O.; Ali, H.M.
    • Year: 2024

 

  • Involvement of Nrf2, JAK and COX Pathways in Acetaminophen-Induced Nephropathy: Role of Some Antioxidants
    • Authors: Alqahtani, Q.H.; Fadda, L.M.; Alhusaini, A.M.; Hasan, I.H.; Ali, H.M.
    • Year: 2023

 

  • Impact of HIF1-α/TGF-β/Smad-2/Bax/Bcl2 Pathways on Cobalt Chloride-Induced Cardiac and Hepatorenal Dysfunction
    • Authors: Kadry, M.O.; Ali, H.M.
    • Year: 2023

 

  • Genetic Diversity of Irradiated Galleria mellonella with Sub-Sterile and Sterile Doses Assessed by SCOT
    • Authors: Ali, H.M.; Sayed, R.M.
    • Year: 2022

 

  • Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR
    • Authors: Alhusaini, A.M.; Fadda, L.M.; Alanazi, A.M.; Hasan, I.H.; Ali, R.A.
    • Year: 2022

 

  • The Potential Protective Effect of Curcumin and α-Lipoic Acid on N-(4-Hydroxyphenyl) Acetamide-Induced Hepatotoxicity Through Downregulation of α-SMA and Collagen III Expression
    • Authors: Alhusain, A.; Fadda, L.; Sarawi, W.; Hasan, I.; Badr, A.
    • Year: 2022

 

  • Chitosan Nanoparticles as a Promising Candidate for Liver Injury Induced by 2-Nitropropane: Implications of P53, iNOS, VEGF, PCNA, and CD68 Pathways
    • Authors: Shaheen, S.; Arafah, M.M.; Alshanwani, A.R.; Alharbi, F.M.B.; AlHarthii, A.
    • Year: 2021

 

  • Manipulation of Quercetin and Melatonin in the Down-Regulation of HIF-1α, HSP-70, and VEGF Pathways in Rat’s Kidneys Induced by Hypoxic Stress
    • Authors: Alshanwani, A.R.; Shaheen, S.; Faddah, L.M.; Alharbi, F.M.B.; AlHarthii, A.
    • Year: 2020

 

Conclusion

Dr. Hanaa Mahmoud Sayed Ali exemplifies excellence in academia and research. Her extensive experience, dedication to teaching, and contributions to interdisciplinary projects highlight her as a leader in her field. With a strong foundation in Zoology and Genetics, she continues to drive impactful research and inspire future generations of scientists.

 

 

Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist Award 

Published on by Neuroscientists

Mr. Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist Award 

Mr. Md Shimul Bhuia , BioLuster Research Center Limited,  Bangladesh.

An accomplished pharmacist and researcher with expertise in pharmaceutical sciences, molecular docking, and drug development. Awarded the prestigious National Science and Technology Fellowship (NST) in 2023 for contributions to science. Extensive experience includes an internship at Beximco Pharmaceuticals, part-time pharmacy practice, and a full-time role as Deputy Director at BioLuster Research Center. Proficient in advanced software for computational drug design and well-versed in research methodologies. Fluent in Bangla and highly proficient in English, with strong technical and analytical skills.

 

profile

scholor

🎓 Education and Academic Achievements

Master of Pharmacy (M. Pharm.) Department of Pharmacy, Life Science Faculty. Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, Bangladesh Session: 2020–2021 Course Duration: 1.5 years (3 Semesters)Passing Year: 2022 CGPA: 3.74 (out of 4.00). Bachelor of Pharmacy (B. Pharm.) Department of Pharmacy, Life Science Faculty .Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, BangladeshSession: 2016–2017  Course Duration: 4 years Hon’s (8 Semesters) Passing Year: 2020 CGPA: 3.45 (out of 4.00)  Higher Secondary Certificate (H.S.C.)  Shahid Bul Bul Govt. College, Pabna Board: Rajshahi Group: Science Passing Year: 2016 GPA: 5.00 (out of 5.00) Secondary School Certificate (S.S.C.) Kamal Pur T.M. High School, Ishwardi, Pabna Board: Rajshahi  Group: Science Passing Year: 2013 GPA: 5.00 (out of 5.00).

🎯 Research Interests

Neurology/Neurodegenerative Diseases , Immunology ,  Cancer Therapy , Toxicology , Molecular Docking , Drug Design and Development via Computational Studies ,Pharmacological Investigation through Preclinical Test Systems , Inflammatory Diseases , Bioinformatics , Anti-cancer Agents

🏆 Honours and Awards

National Science and Technology Fellowship (NST), 2023. Awarded by the Ministry of Science and Technology, Government of Bangladesh

💼 Work Experiences

InternshipBeximco Pharmaceutical Ltd., Squibb Road, Tongi, Bangladesh Duration: November 13, 2022, to November 23, 2022. Pharmacist Worked as a pharmacist at Gafur Chikitsaloi (local pharmacy shop)Employee Status: Part-Researcher Deputy Director, BioLuster Research Center, Gopalganj 8100, Dhaka, Bangladesh Employee Status: Full-time (January 01 – Present)

📚 Publications

 

 Conclusion

With a strong foundation in both clinical practice and academic leadership, Leila Sadati’s career reflects a commitment to advancing healthcare education and patient safety standards. Her contributions in research, curriculum development, and operational management have shaped future medical professionals and enhanced patient care practices. As she continues to innovate and educate, her work remains instrumental in raising the standards of medical and surgical education in Iran and beyond.